Alteration of pharmacokinetics after halving a slow-release theophylline tablet

Alteration of pharmacokinetics after halving a slow-release theophylline tablet

A study was carried out in 10 healthy volunteers to determine the effects on the bioavailability of theophylline from a biconvex-shaped, slow-release 400 mg theophylline tablet formulation when the tablet was taken whole or as two separate halves in a single dose. The subjects took one or other dosa...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC). - 1995. - 3(1983), 6 vom: 16., Seite 429-32
1. Verfasser: Primrose, W R (VerfasserIn)
Weitere Verfasser: Clee, M D, Moody, J P, Hockings, N
Format: Aufsatz
Sprache:English
Veröffentlicht: 1983
Zugriff auf das übergeordnete Werk:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)
Schlagworte:Clinical Trial Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Delayed-Action Preparations Tablets Theophylline C137DTR5RG